A significant proportion of thalassemia major patients have adrenal insufficiency detectable on provocative testing

Journal of Pediatric Hematology/Oncology

Volumn 37, Issue 1, 2015, Pages 54-59

  Huang, Karen E ^a,b   Mittelman, Steven D ^a,b   Coates, Thomas D ^c   Geffner, Mitchell E ^a,b   Wood, John C ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

^c Division of Hematology Oncology   (United States)

Author keywords

adrenal insufficiency; iron overload; thalassemia

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DEFERASIROX; DEFERIPRONE; DEFEROXAMINE; HYDROCORTISONE; GLUCAGON;

ADOLESCENT; ADRENAL INSUFFICIENCY; ADULT; ARTICLE; CAUSE OF DEATH; CHELATION THERAPY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN TEST; FEMALE; HUMAN; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IRON OVERLOAD; MALE; MORBIDITY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PREVALENCE; PROSPECTIVE STUDY; PROVOCATION TEST; RISK FACTOR; SCHOOL CHILD; SEPSIS; THALASSEMIA MAJOR; BETA THALASSEMIA; BLOOD; COMPLICATION; SEXUAL DEVELOPMENT;

ADOLESCENT; ADRENAL INSUFFICIENCY; ADRENOCORTICOTROPIC HORMONE; ADULT; BETA-THALASSEMIA; CHILD; FEMALE; GLUCAGON; HUMANS; HYDROCORTISONE; MALE; PREVALENCE; PROSPECTIVE STUDIES; SEX CHARACTERISTICS;

EID: 84920603985     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0000000000000199     Document Type: Article

References (37)

1. Elsedfy HH, El KM, Tarif R, et al. Adrenal function in thalassemia major adolescents. Pediatr Endocrinol Rev. 2011;8(suppl 2):S295-S299.
2. Jaruratanasirikul S, Tanchotikul S, Wongcharnchailert M, et al. A low dose adrenocorticotropin test (1 microg ACTH) for the evaluation of adrenal function in children with beta-thalassemia receiving hypertransfusion with suboptimal iron-chelating therapy. J Pediatr Endocrinol Metab. 2007;20: 1183-1188.
3. Srivatsa A, Marwaha RK, Muraldharan R, et al. Assessment of adrenal endocrine function in Asian thalassemics. Indian Pediatr. 2005;42:31-35.
4. Gulati R, Bhatia V, Agarwal SS. Early onset of endocrine abnormalities in beta-thalassemia major in a developing country. J Pediatr Endocrinol Metab. 2000;13:651-656.
5. Scacchi M, Danesi L, Cattaneo A, et al. The pituitary-adrenal axis in adult thalassaemic patients. Eur J Endocrinol. 2010; 162:43-48.
6. Wood JC. Cardiac complications in thalassemia major. Hemoglobin. 2009;33(suppl 1):S81-S86.
7. Telfer P. Update on survival in thalassemia major. Hemoglobin. 2009;33(suppl 1):S76-S80.
8. Noetzli LJ, Panigrahy A, Mittelman SD, et al. Pituitary iron and volume predict hypogonadism in transfusional iron overload. Am J Hematol. 2011;87:167-171.
9. Geffner ME, Karlsson H. Use of recombinant human growth hormone in children with thalassemia. Horm Res. 2009; 71(suppl 1):S46-S50.
10. Banani SA, Omrani GH. Cortisol and adrenocorticotropic hormone response to surgical stress (splenectomy) in thalasse-mic patients. Pediatr Surg Int. 2000;16:400-403.
11. Sklar CA, Lew LQ, Yoon DJ, et al. Adrenal function in thalassemia major following long-term treatment with multiple transfusions and chelation therapy. Evidence for dissociation of cortisol and adrenal androgen secretion. Am J Dis Child. 1987;141:327-330.
12. Rao RH, Spathis GS. Intramuscular glucagon as a provocative stimulus for the assessment of pituitary function: growth hormone and cortisol responses. Metabolism. 1987;36:658-663.
13. Lytras N, Grossman A, Perry L, et al. Corticotropin releasing factor: responses in normal subjects and patients with disorders of the hypothalamus and pituitary. Clin Endocrinol (Oxf). 1984;20:71-84.
14. Orth DN, Jackson RV, DeCherney GS, et al. Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisol. J Clin Invest. 1983;71:587-595.
15. Di Iorgi N, Napoli F, Allegri A, et al. The accuracy of the glucagon test compared to the insulin tolerance test in the diagnosis of adrenal insufficiency in young children with growth hormone deficiency. J Clin Endocrinol Metab. 2010;95:2132-2139.
16. Berg C, Meinel T, Lahner H, et al. Diagnostic utility of the glucagon stimulation test in comparison to the insulin tolerance test in patients following pituitary surgery. Eur J Endocrinol. 2010; 162: 477-482.
17. Bottner A, Kratzsch J, Liebermann S, et al. Comparison of adrenal function tests in children-the glucagon stimulation test allows the simultaneous assessment of adrenal function and growth hormone response in children. J Pediatr Endocrinol Metab. 2005;18:433-442.
18. De Sanctis V, Skordis N, Galati MC, et al. Growth hormone and adrenal response to intramuscular glucagon test and its relationship to IGF-1 production and left ventricular ejection fraction in adult B-thalassemia major patients. Pediatr Endocrinol Rev. 2011;8(suppl 2):S290-S294.
19. Noetzli LJ, Papudesi J, Coates TD, et al. Pancreatic iron loading predicts cardiac iron loading in thalassemia major. Blood. 2009;114:4021-4026.
20. Wood JC, Noetzli L. Cardiovascular MRI in thalassemia major. Ann N Y Acad Sci. 2010;1202:173-179.
21. Wood JC, Enriquez C, Ghugre N, et al. MRI R2 and R2∗ mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood. 2005;106:1460-1465.
22. Poomthavorn P, Isaradisaikul B, Chuansumrit A, et al. High prevalence of "biochemical" adrenal insufficiency in thalasse-mics: is it a matter of different testings or decreased cortisol binding globulin? J Clin Endocrinol Metab. 2010;95:4609-4615.
23. Borgna-Pignatti C, Rugolotto S, De SP, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004;89: 1187-1193.
24. Marsella M, Pepe A, Borgna-Pignatti C. Better survival and less cardiac morbidity in female patients with thalassemia major: a review of the literature. Ann N Y Acad Sci. 2010;1202:129-133.
25. Kyriakou A, Savva SC, Savvides I, et al. Gender differences in the prevalence and severity of bone disease in thalassaemia. Pediatr Endocrinol Rev. 2008;6(suppl 1):S116-S122.
26. Noetzli LJ, Mittelman SD, Watanabe RM, et al. Pancreatic iron and glucose dysregulation in thalassemia major. Am J Hematol. 2011;87:155-160.
27. Tauchmanova L, Selleri C, Rosa GD, et al. High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases. Cancer. 2002;95:1076-1084.
28. Arvat E, Maccagno B, Ramunni J, et al. Interaction between glucagon and hexarelin, a peptidyl GH secretagogue, on somatotroph and corticotroph secretion in humans. Eur J Endocrinol. 2000;143:601-606.
29. Arvat E, Maccagno B, Ramunni J, et al. Interaction between glucagon and human corticotropin-releasing hormone or vasopressin on ACTH and cortisol secretion in humans. Eur J Radiol. 2000;143:99-104.
30. Broglio F, Prodam F, Gottero C, et al. Ghrelin does not mediate the somatotroph and corticotroph responses to the stimulatory effect of glucagon or insulin-induced hypoglycae-mia in humans. Clin Endocrinol (Oxf). 2004;60:699-704.
31. Moos T, Rosengren NT, Skjorringe T, et al. Iron trafficking inside the brain. J Neurochem. 2007;103:1730-1740.
32. Roth C, Pekrun A, Bartz M, et al. Short stature and failure of pubertal development in thalassaemia major: evidence for hypothalamic neurosecretory dysfunction of growth hormone secretion and defective pituitary gonadotropin secretion. Eur J Pediatr. 1997;156:777-783.
33. Cavallo L, Gurrado R, Gallo F, et al. Growth deficiency in polytransfused beta-thalassaemia patients is not growth hormone dependent. Clin Endocrinol (Oxf). 1997;46:701-706.
34. Christophe C, Van VG, Dooms G, et al. Panhypopituitarism without diabetes insipidus: magnetic resonance imaging of pituitary stalk transection. Eur J Pediatr. 1990;149:235-236.
35. Vaisman N, Akivis A, Sthoeger D, et al. Resting energy expenditure in patients with thalassemia major. Am J Clin Nutr. 1995;61:582-584.
36. Loucks AB, Mortola JF, Girton L, et al. Alterations in the hypothalamic-pituitary-ovarian and the hypothalamic-pitui-tary-adrenal axes in athletic women. J Clin Endocrinol Metab. 1989;68:402-411.
37. Borgna-Pignatti C, Cappellini MD, De SP, et al. Survival and complications in thalassemia. Ann N Y Acad Sci. 2005;1054:40-47.